A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Name: A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

combination disease-progression drug-resistance drug-therapy genotype hiv-1 hiv-infections rna

hiv infections, hiv-1, drug resistance, drug therapy, combination, hiv protease inhibitors, cd4 lymphocyte count, ritonavir, indinavir, disease progression, rna, viral, genotype, nelfinavir

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 966461
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.